Market by Product, Application, End-user, and Country | Forecast 2019-2028
As per Triton’s research report, the Middle East and African neurorehabilitation device market is anticipated to surge with a CAGR of 13.63% in the forecasting years of 2019-2028.
Report scope can be customized per your requirements. Request For Customization
The
countries reviewed in this market are:
• Saudi Arabia
• Turkey
• The UAE
• South Africa
• Rest of MEA countries
In
2017, the number of people affected by Alzheimer’s disease (AD) in Saudi Arabia
accounted for 1227 people, as per the Saudi Alzheimer’s Disease Association. In
2020, the nation’s Ministry of Health, put forth that the incidence of AD
doubles every five years after a person reaches 65 years of age. The number of
disease cases is projected to grow nearly three times by 2060, reaching 14
million people. Thus, the rising prevalence of Alzheimer’s in Saudi Arabia,
along with a growing geriatric populace, is expected to augment the demand for
neurorehabilitation devices. This factor, in turn, is expected to boost the
growth of the nation’s neurorehabilitation device market in the coming years.
The
growth of the UAE’s neurorehabilitation device market is attributable to the
high prevalence of stroke in the country, along with investments for research
in dementia and Alzheimer’s disease. The Dubai Health Authority (DHA) states
that, one person gets a stroke in the country every hour. Also, 7,000-8,000
cases of stroke are reported every year. The prevalence of AD could rise by
more than 600% over the next 15 years, unless preventative measures are
implemented. This is a matter of grave concern. The growing pervasiveness of
neurological diseases demands the adoption of neurorehabilitation devices on a
large scale. Further, the growth in people’s income and the continuous improvement
in the national healthcare system are also factors enhancing the demand for
these devices. The growing demand for neurorehabilitation devices is propelling
the growth of the studied market in the United Arab Emirates.
Established
in 2010, Bioxtreme is a company headquartered in Israel. It develops robotics
rehabilitation systems for stroke, traumatic brain injury (TBI), and other
neurological disorders. The company develops products based on the ‘Error
Enhancement Technology,’ a patented technology of the company. The company
claims that its system saves 50% on the rehabilitation treatment time.
1. MIDDLE
EAST AND AFRICA NEUROREHABILITATION DEVICE MARKET - SUMMARY
2. INDUSTRY
OUTLOOK
2.1. MARKET
DEFINITION
2.2. PORTER’S
FIVE FORCES MODEL
2.2.1. THREAT
OF NEW ENTRANTS
2.2.2. THREAT
OF SUBSTITUTE PRODUCTS
2.2.3. BARGAINING
POWER OF BUYERS
2.2.4. BARGAINING
POWER OF SUPPLIERS
2.2.5. COMPETITIVE
RIVALRY
2.3. SUPPLY
CHAIN OUTLOOK
2.4. IMPACT
OF CORONAVIRUS ON NEUROREHABILITATION DEVICE MARKET
2.5. ETYMOLOGY
OF NEUROREHABILITATION DEVICE
2.6. KEY
IMPACT ANALYSIS
2.7. MARKET
ATTRACTIVENESS INDEX
2.8. KEY
INSIGHTS
2.9. MARKET
DRIVERS
2.9.1. RISE
IN GERIATRIC POPULATION
2.9.2. GROWING
EMERGENCE OF NEUROREHABILITATION WEARABLES AND ROBOTICS
2.9.3. RISING
PREVALENCE OF NEUROLOGICAL DISEASES
2.10. MARKET RESTRAINTS
2.10.1. LACK OF SKILLED WORKFORCE TO
TREAT AND MANAGE NEUROLOGICAL DISEASES
2.10.2.HIGH COST OF TREATMENT
2.11. MARKET OPPORTUNITIES
2.11.1. ADVANCEMENTS IN TECHNOLOGY
2.11.2. RISING INCIDENCE OF
NEUROLOGICAL DISORDERS IN DEVELOPING ECONOMIES
2.12. MARKET CHALLENGES
2.12.1. STRINGENT GOVERNMENT
REGULATIONS
3. NEUREHABILITATION
DEVICE MARKET OUTLOOK - BY PRODUCT
3.1. NEURO-ROBOTIC
SYSTEM
3.2. BRAIN-COMPUTER
INTERFACE
3.3. WEARABLE
DEVICE
3.4. NON-INVASIVE
STIMULATOR
3.5. OTHER
PRODUCTS
4. NEUREHABILITATION
DEVICE MARKET OUTLOOK - BY APPLICATION
4.1. STROKE
4.2. CEREBRAL
PALSY
4.3. PARKINSON’S
DISEASE
4.4. MULTIPLE
SCLEROSIS
4.5. OTHER
APPLICATIONS
5. NEUREHABILITATION
DEVICE MARKET OUTLOOK - BY END-USER
5.1. HOSPITAL/CLINIC
5.2. RESEARCH
INSTITUTE
5.3. COGNITIVE
CARE CENTER
5.4. OTHER
END-USER
6. NEUREHABILITATION
DEVICE MARKET – MIDDLE EAST AND AFRICA
6.1. COUNTRY
ANALYSIS
6.1.1. SAUDI
ARABIA
6.1.2. UNITED
ARAB EMIRATES
6.1.3. TURKEY
6.1.4. SOUTH
AFRICA
6.1.5. REST
OF MIDDLE EAST & AFRICA
7. COMPANY
PROFILES
7.1. BIONIK
LABORATORIES CORP
7.2. TYROMOTION
GMBH
7.3. BIOXTREME
7.4. ECTRON
LIMITED
7.5. KINOVA
7.6. ABBOTT
LABORATORIES
7.7. BIOMETRICS
LTD
7.8. REHA
TECHNOLOGY AG
7.9. MEDTRONIC
INC
7.10. HELIUS MEDICAL TECHNOLOGIES
7.11. HOKOMA AG
7.12. KINESTICA
7.13. SAEBO
7.14. NEUROSTYLE PTE LTD
7.15. EKSO BIONICS HOLDINGS INC
8. RESEARCH
METHODOLOGY & SCOPE
8.1. RESEARCH
SCOPE & DELIVERABLES
8.1.1. OBJECTIVES
OF STUDY
8.1.2. SCOPE
OF STUDY
8.2. SOURCES
OF DATA
8.2.1. PRIMARY
DATA SOURCES
8.2.2. SECONDARY
DATA SOURCES
8.3. RESEARCH
METHODOLOGY
8.3.1. EVALUATION
OF PROPOSED MARKET
8.3.2. IDENTIFICATION
OF DATA SOURCES
8.3.3. ASSESSMENT
OF MARKET DETERMINANTS
8.3.4. DATA
COLLECTION
8.3.5. DATA
VALIDATION & ANALYSIS
TABLE
1 MIDDLE EAST AND AFRICA
NEUROREHABILITATION DEVICE MARKET, BY COUNTRY, 2019-2028 (IN $ MILLION)
TABLE
2 MIDDLE EAST AND AFRICA
NEUROREHABILITATION DEVICE MARKET, BY PRODUCT, 2019-2028 (IN $ MILLION)
TABLE
3 MIDDLE EAST AND AFRICA
NEUROREHABILITATION DEVICE MARKET, BY APPLICATION, 2019-2028 (IN $ MILLION)
TABLE
4 MIDDLE EAST AND AFRICA
NEUROREHABILITATION DEVICE MARKET, BY END-USER, 2019-2028 (IN $ MILLION)
TABLE
5 MIDDLE EAST AND AFRICA
NEUROREHABILITATION DEVICE MARKET, BY COUNTRY, 2019-2028 (IN $ MILLION)
FIGURE
1 MIDDLE EAST AND AFRICA
NEUROREHABILITATION DEVICE MARKET 2019-2028 (IN $ MILLION)
FIGURE
2 SUPPLY CHAIN OUTLOOK FOR
NEUROREHABILITATION DEVICE MARKET
FIGURE
3 ETYMOLOGY OF NEUROREHABILITATION
DEVICE MARKET
FIGURE
4 MIDDLE EAST AND AFRICA
NEUROREHABILITATION DEVICE MARKET, BY NEURO-ROBOTIC SYSTEM, 2019-2028 (IN $
MILLION)
FIGURE
5 MIDDLE EAST AND AFRICA
NEUROREHABILITATION DEVICE MARKET, BY BRAIN-COMPUTER INTERFACE, 2019-2028 (IN $
MILLION)
FIGURE
6 MIDDLE EAST AND AFRICA
NEUROREHABILITATION DEVICE MARKET, BY WEARABLE DEVICE, 2019-2028 (IN $ MILLION)
FIGURE
7 MIDDLE EAST AND AFRICA
NEUROREHABILITATION DEVICE MARKET, BY NON-INVASIVE STIMULATOR, 2019-2028 (IN $
MILLION)
FIGURE
8 MIDDLE EAST AND AFRICA
NEUROREHABILITATION DEVICE MARKET, BY OTHER PRODUCTS, 2019-2028 (IN $ MILLION)
FIGURE
9 MIDDLE EAST AND AFRICA
NEUROREHABILITATION DEVICE MARKET, BY STROKE, 2019-2028 (IN $ MILLION)
FIGURE
10 MIDDLE EAST AND AFRICA
NEUROREHABILITATION DEVICE MARKET, BY CEREBRAL PALSY, 2019-2028 (IN $ MILLION)
FIGURE
11 MIDDLE EAST AND AFRICA NEUROREHABILITATION
DEVICE MARKET, BY PARKINSON’S DISEASE, 2019-2028 (IN $ MILLION)
FIGURE
12 MIDDLE EAST AND AFRICA
NEUROREHABILITATION DEVICE MARKET, BY MULTIPLE SCLEROSIS, 2019-2028 (IN $
MILLION)
FIGURE
13 MIDDLE EAST AND AFRICA
NEUROREHABILITATION DEVICE MARKET, BY OTHER APPLICATIONS, 2019-2028 (IN $
MILLION)
FIGURE
14 MIDDLE EAST AND AFRICA
NEUROREHABILITATION DEVICE MARKET, BY HOSPITAL/CLINIC, 2019-2028 (IN $ MILLION)
FIGURE
15 MIDDLE EAST AND AFRICA
NEUROREHABILITATION DEVICE MARKET, BY RESEARCH INSTITUTE, 2019-2028 (IN $
MILLION)
FIGURE
16 MIDDLE EAST AND AFRICA
NEUROREHABILITATION DEVICE MARKET, BY COGNITIVE CARE CENTER, 2019-2028 (IN $
MILLION)
FIGURE
17 MIDDLE EAST AND AFRICA
NEUROREHABILITATION DEVICE MARKET, BY OTHER END-USER, 2019-2028 (IN $ MILLION)
FIGURE
18 SAUDI ARABIA NEUROREHABILITATION
DEVICE MARKET 2019-2028 (IN $ MILLION)
FIGURE
19 UNITED ARAB EMIRATES
NEUROREHABILITATION DEVICE MARKET 2019-2028 (IN $ MILLION)
FIGURE
20 TURKEY NEUROREHABILITATION DEVICE
MARKET 2019-2028 (IN $ MILLION)
FIGURE
21 SOUTH AFRICA NEUROREHABILITATION
DEVICE MARKET 2019-2028 (IN $ MILLION)
FIGURE
22 REST OF MIDDLE EAST & AFRICA
NEUROREHABILITATION DEVICE MARKET 2019-2028 (IN $ MILLION)